Common Deleterious Germline Variants Shape the Urothelial Cancer Genome
Demographics (3)
- AGE - Age at end of follow-up period (phv00266320.v4.p1)
- GENDER - Gender of participant (phv00266319.v4.p1)
- SEX - Biological sex (phv00504582.v1.p1)
Disease Events (3)
- HIGHEST_RECORDED_CLINICAL_TNM_STAGE - The highest clinical TNM stage of the patient recorded (phv00266323.v4.p1)
- HISTOPATOLOGY_PRIMARY_TUMOR - Histopathology of the primary tumor of the patient (phv00266322.v4.p1)
- IS_TUMOR - Tumor status (phv00266327.v4.p1)
Medications (2)
- CHEMOTHERAPY - Chemotherapy or intravesical therapy received prior to sample acquisition (phv00266329.v4.p1)
- CHEMOTHERAPY_STATUS - Is the sample treated prior acquisition (phv00266330.v4.p1)
Substance Use (1)
- SMOKING_STATUS - Is the subject a smoker (phv00266321.v4.p1)
Other (11)
- ANALYTE_TYPE - Analyte type (phv00266326.v4.p1)
- BODY_SITE - Body site where sample was collected (phv00266325.v4.p1)
- CONSENT - Consent group as determined by DAC (phv00266313.v4.p1)
- PRIMARY_METASTATIC_TUMOR - The tumor is primary or metastatics (phv00266328.v4.p1)
- pT_diagnosis - PT state diagnosis (phv00409114.v3.p1)
- SAMPLE_ID - De-identified Sample ID (phv00266324.v4.p1)
- SAMPLE_ID - Sample ID (phv00266316.v4.p1)
- SUBJECT_ID - De-identified Subject ID (phv00266318.v4.p1)
- SUBJECT_ID - Subject ID (phv00266312.v4.p1)
- SUBJECT_ID - Subject ID (phv00266315.v4.p1)
- TUMOR_GRADE - Tumor grade (phv00409115.v3.p1)